Show simple item record

dc.contributor.authorKotz, Deborah
dc.date.accessioned2020-06-01T14:13:53Z
dc.date.available2020-06-01T14:13:53Z
dc.date.issued2020-05-28
dc.identifier.urihttp://hdl.handle.net/10713/12894
dc.descriptionNews release announcing that researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe. Additional information available via the accompanying video.en_US
dc.description.urihttps://youtu.be/ND6suElbZw4en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectMesoblast Limiteden_US
dc.subjectremestemcel-Len_US
dc.subject.lcshUniversity of Maryland, Baltimoreen_US
dc.subject.lcshUniversity of Maryland Medical Centeren_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.meshStem Cell Researchen_US
dc.subject.meshCOVID-19en_US
dc.titleCOVID-19 Stem Cell Treatment Tested at UMBen_US
dc.typeArticleen_US
dc.typeVideoen_US
refterms.dateFOA2020-06-01T14:13:54Z


Files in this item

Thumbnail
Name:
COVID-19StemCellTreatment_2020 ...
Size:
296.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record